The mission of IBX is to understand the genetic causes of common, complex diseases and to discover diagnoses, treatments and, eventually, cures for these diseases. To this end, we collaborate with researchers in the public and private sectors throughout the world, providing the highest quality biobanking services and biomaterials, as well as scientific and technical support.
As the world’s largest university-based biorepository, IBX has been perfecting the science of biobanking, bioprocessing and analytics since 1999. By utilizing a technologically advanced infrastructure and the highest quality biomaterials, IBX scientists work to convert precious biosamples into renewable resources thereby extending research capabilities. IBX understands that research goals and objectives vary from project to project so we give each client individual and customized attention to ensure “best fit” service.
Cap Biorepository Accreditation
IBX is accredited by the College of American Pathologists, a worldwide leader in laboratory quality assurance.
In 2012, the College accredited IBX through its Biorepository Accreditation Program, making the operation at Rutgers one of the first in the world to earn this designation.
Clinical Laboratory Improvement Amendments (CLIA) License
ISBER Gold Member
IBX adheres to “ISBER Best Practices” guidelines, considered by many to be the gold standard in Biobanking practices.
IBX has a long standing relationship with The International Society for Biological and Environmental Repositories (ISBER) and is currently an ISBER Gold Member Corporate Partner. IBX leadership actively contributes to the ISBER organization by: participating as invited speakers; serving on the ISBER Executive Council and the Editorial Board for Biopreservation and Biobanking (BIO), the official journal of ISBER; chairing ISBER affiliated Working Groups; presenting scientific posters and biobanking related abstracts and leading member attended workshops at domestic and international meetings.